A detailed history of Wolverine Trading, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Wolverine Trading, LLC holds 11,162 shares of PRTA stock, worth $163,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,162
Holding current value
$163,300
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$11.95 - $18.35 $133,385 - $204,822
11,162 New
11,162 $154,000
Q3 2022

Nov 14, 2022

BUY
$25.16 - $60.63 $372,493 - $897,627
14,805 New
14,805 $880,000
Q4 2019

Feb 12, 2020

BUY
$7.48 - $17.01 $150,789 - $342,904
20,159 New
20,159 $318,000
Q1 2019

May 15, 2019

SELL
$10.32 - $14.49 $132,271 - $185,718
-12,817 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$8.73 - $13.74 $84,654 - $133,236
-9,697 Reduced 43.07%
12,817 $131,000
Q3 2018

Nov 14, 2018

BUY
$12.7 - $15.79 $285,927 - $355,496
22,514 New
22,514 $294,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $686M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.